The role of excitotoxicity in neurodegenerative disease: implications for therapy

A Doble - Pharmacology & therapeutics, 1999 - Elsevier
Glutamic acid is the principal excitatory neurotransmitter in the mammalian central nervous
system. Glutamic acid binds to a variety of excitatory amino acid receptors, which are ligand …

Major depression and activation of the inflammatory response system

M Maes - Cytokines, stress, and depression, 1999 - Springer
Contemporary models of major depression emphasize the role of hypothalamic-pituitary-
adrenal (HPA)-axis hyperactivity and of dysfunctions in the turnover of serotonin (5-HT) or …

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

F Moroni - European journal of pharmacology, 1999 - Elsevier
The synthesis of NAD (or NADP) from tryptophan involves a series of enzymes and the
formation of a number of intermediates which are collectively calledkynurenines.'In the late …

Redox reactions related to indoleamine 2, 3-dioxygenase and tryptophan metabolism along the kynurenine pathway

SR Thomas, R Stocker - Redox Report, 1999 - Taylor & Francis
Abstract The heme enzyme indoleamine 2, 3-dioxygenase (IDO) oxidizes the pyrrole moiety
of L-tryptophan (Trp) and other indoleamines and represents the initial and rate-limiting …

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection

S Staprans, N Marlowe, D Glidden… - Aids, 1999 - journals.lww.com
Objectives: To compare the kinetics and magnitude of HIV-1 RNA responses to antiretroviral
therapy (ART) in the cerebrospinal fluid (CSF) and plasma. Design: Repeated lumbar …

Pathobiology of human immunodeficiency virus dementia

A Nath - Seminars in neurology, 1999 - thieme-connect.com
The pathobiology of dementia that accompanies infection with the human immunodeficiency
virus involves complex interactions of the virus with the host. The virus enters the brain either …

Degradation of tryptophan in neurodegenerative disorders

B Widner, F Leblhuber, J Walli, GP Tilz… - … , and Melatonin: Basic …, 1999 - Springer
In patients with neurodegenerative disorders, namely Alzheimer's disease and Huntington's
disease, we compared serum concentrations of tryptophan, kynurenine and the kynurenine …

Evidence for increased de novo synthesis of NAD in immune-activated RAW264. 7 macrophages: a self-protective mechanism?

RS Grant, R Passey, G Matanovic, G Smythe… - Archives of biochemistry …, 1999 - Elsevier
The parent pyridine nucleotide NAD is the end product of oxidative tryptophan catabolism
via the kynurenine pathway. Indoleamine 2, 3-dioxygenase, the rate-limiting enzyme for this …

Quinolinic acid, α-picolinic acid, fusaric acid, and 2, 6-pyridinedicarboxylic acid enhance the Fenton reaction in phosphate buffer

H Iwahashi, H Kawamori, K Fukushima - Chemico-biological interactions, 1999 - Elsevier
Quinolinic acid, α-picolinic acid, fusaric acid, and 2, 6-pyridinedicarboxylic acid enhanced
the Fenton reaction in phosphate buffer, respectively. The enhancement by quinolinic acid, α …

Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury

MJ Bell, PM Kochanek, MP Heyes… - Critical care …, 1999 - journals.lww.com
Quinolinic acid in the cerebrospinal fluid of children after... : Critical Care Medicine Quinolinic
acid in the cerebrospinal fluid of children after traumatic brain injury : Critical Care Medicine …